1-6 of 6
Robert L Schlossman, M.D.
Close
Sort by
Journal Articles

Lack of Response to Vaccination in MGUS and Stable Myeloma.

Rao H Prabhala, PhD, Yvonne A Efebera, MD, Saem Lee, Andrew J Han, Dheeraj Pelluru, Puru Nanjappa, MS, Samir Amin, Christine Pai, Irene Ghobrial, M.D., Robert L Schlossman, M.D., Ph.D., Jacob Laubach, Mariateresa Fulciniti, Paul Richardson, M.D., Ph.D., Kenneth C. Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2009) 114 (22): 1852.
https://doi.org/10.1182/blood.V114.22.1852.1852
Published: 2009
Journal Articles

Perifosine in Combination with Bortezomib and Dexamethasone Extends Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Bortezombib: Updated Phase I/II Trial Results.

Paul Richardson, M.D., Ph.D., Jeffrey Lee Wolf, MD, Andrzej Jakubowiak, MD, PhD, Jeffrey A. Zonder, MD, Sagar Lonial, MD, David H Irwin, MD, Amrita Krishnan, MD, John Densmore, MD, PhD, Noopur Raje, MD, Michael H. Bar, MD, Robert L Schlossman, M.D., Ph.D., Irene Ghobrial, MD, Nikhil C. Munshi, MD, Thomas Martin, MD, Jacob Laubach, MD, Jeffrey P. Allerton, MD, Teru Hideshima, MD, PhD, Lesa Gardner, RN, Peter Sportelli, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 1869.
https://doi.org/10.1182/blood.V114.22.1869.1869
Published: 2009
Journal Articles

An Open-Label Phase I Study of the Safety and Efficacy of RAD001 in Combination with Lenalidomide in the Treatment of Patients with Relapsed and Relapsed/Refractory Multiple Myeloma.

Noopur Raje, MD., Paul Richardson, M.D., Parameswaran N Hari, MD, Anuj Mahindra, Sarah Kaster, BS, Christine Connolly, Linda Rivera, Gaurav Chetri, Sarah Dean, Paulette Jacobs, Ayman Saad, MD, Jacob Laubach, Irene M. Ghobrial, M.D., Robert L Schlossman, M.D., Ph.D., Jennifer Adams, Wendy Makrides, Edie Weller, PhD, Nikhil Munshi, M.D., Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3856.
https://doi.org/10.1182/blood.V114.22.3856.3856
Published: 2009
Journal Articles

NPI-2358, a Novel Vascular Disrupting Agent Blocks Growth and Angiogenesis in Multiple Myeloma Cells.

Dharminder Chauhan, Ph.D, Ajita V. Singh, Madhavi Bandi, Noopur Raje, M.D., Robert L Schlossman, M.D., G. Kenneth Lloyd, PhD, Paul Richardson, Michael A. Palladino, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3842.
https://doi.org/10.1182/blood.V114.22.3842.3842
Published: 2009
Journal Articles

Targeting MEK1/2 Signaling Cascade by AS703026, a Novel Selective MEK1/2 Inhibitor, Induces Pleiotropic Anti-Myeloma Activity in Vitro and In Vivo.

Yu-Tzu Tai, Ph.D., Kihyun Kim, M.D., Xian-Feng Li, M.S., Mariateresa Fulciniti, Ph.D., Weihua Song, M.D., Sabikun Nahar, B.S., Peter Burger, B.S., Mathew J. Rumizen, Klaus Podar, M.D., Ph.D., Dharminder Chauhan, Ph.D, Teru Hideshima, M.D., Ph.D., Robert L Schlossman, M.D., Ph.D., Nikhil C. Munshi, Paul Richardson, M.D., Ph.D., Ann Clark, Ph.D., Janet Ogden, Ph.D., Goutopoulos Andreas, Ph.D., Luca Rastelli, Ph.D., Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3848.
https://doi.org/10.1182/blood.V114.22.3848.3848
Published: 2009
Journal Articles

Phase II Trial of Weekly Bortezomib in Combination with CCI-779 (temsirolimus) in Relapsed or Relapsed/Refractory Multiple Myeloma.

Irene M. Ghobrial, M.D., Ravi Vij, MD, Nikhil C. Munshi, Robert L Schlossman, M.D., Ph.D., Jacob Laubach, Erica L. Campagnaro, MD, Renee Leduc, Meghan Rourke, Stacey Chuma, Janet Kunsman, NP, Akari M. Dollard, Diane Warren, Brianna Harris, Amy Sam, Kenneth C. Anderson, MD, Paul Richardson, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 748.
https://doi.org/10.1182/blood.V114.22.748.748
Published: 2009